2019 Inhibition in the CNS Gordon Research Conference and Gordon Research Seminar

2019年中枢神经系统戈登研究会议和戈登研究研讨会的抑制

基本信息

批准号：
9750981
负责人：
IVAN SOLTESZ
金额：
$ 2万
依托单位：
GORDON RESEARCH CONFERENCES
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-04-01 至 2019-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9750981
关键词：
Address Adult Affect Anxiety Area Attention Axon Benzodiazepines Brain Brain Diseases Cell Communication Central Nervous System Diseases Cognition Collaborations Communities Country Development Disease Educational Status Ensure Epilepsy Europe Exposure to Face Functional disorder Future Gender Geography Goals Growth Health Hour International Internationality Interneurons Knowledge Maine Mediating Mental Depression Mental disorders Mentors Modeling Molecular National Institute of Child Health and Human Development National Institute of Neurological Disorders and Stroke Nature Nervous System Physiology Neuraxis Neuroglia Neurons Neurotransmitters Participant Pathologic Postdoctoral Fellow Request for Proposals Research Research Personnel Resolution Rivers Role Schizophrenia Science Scientist Series Signal Transduction Students Synapses Training Woman Work autism spectrum disorder brain abnormalities career gamma-Aminobutyric Acid graduate student human disease innovation interest meetings myelination nervous system disorder neuronal circuitry neurosteroids neurotransmission posters programs receptor spatiotemporal symposium synaptogenesis targeted treatment training opportunity transmission process

项目摘要

Project Summary The 2019 Gordon Research Conference (GRC) on Inhibition in the Central Nervous System will be held at the Grand Summit Hotel at Sunday River, Newry, Maine, USA, on July 7-12, 2019. This international research conference has been held every 2 years since 2005 as part of the GRC conference series. It will be preceded on July 6 -7, 2019, as in previous editions, by the Gordon Research Seminar (GRS), which is reserved for graduate students and postdocs in order to give them an introduction to the main topics of the GRC. Inhibition, mediated primarily by the neurotransmitter GABA, regulates all aspects of central nervous system (CNS) function and represents a major target for therapeutics. The scientific community working on inhibitory neurotransmission is broad and very dynamic. This GRC provides a major forum bringing together leaders in the field along with rising new stars among early-career investigators. The goal of this meeting is to increase our understanding of the molecular, synaptic and network mechanisms contributing to the critical role of inhibitory neurotransmission in normal and abnormal CNS function. To achieve this goal, the meeting will pursue specific aims that include dissemination of the latest discoveries about inhibition in brain function and dysfunction, promotion of diversity and collaboration within the field, and advancement of the training of graduate students and postdoctoral fellows. These aims will be met by convening 34 world-class speakers and 9 discussion leaders actively working in diverse areas of inhibition from 11 different countries across 3 continents (25 from the US; 20 women), ensuring internationality and diversity. The GRC will accommodate up to 200 participants at a five-day conference in an isolated setting. The health relatedness of this application is that discussions at the Inhibition in the CNS GRC/GRS meetings will define the questions that require experimental resolution in areas related to cognition, development, and a variety of neurological and psychiatric disorders that involve dysregulated inhibition including autism, epilepsy, schizophrenia, anxiety, depression and other diseases. Taken together, it is expected that the scientific discussions, research talks, poster sessions, and various informal interactions between the diverse participants of this conference will advance our understanding of fundamental mechanisms underlying in CNS function and human disease.

项目概要 2019年戈登中枢神经系统抑制研究会议（GRC）将于 2019 年 7 月 7 日至 12 日，美国缅因州纽里周日河格兰德萨米特酒店。这项国际研究该会议自 2005 年起每两年举行一次，作为 GRC 会议系列的一部分。将会先于与之前的版本一样，将于 2019 年 7 月 6 日至 7 日由戈登研究研讨会 (GRS) 举办，该研讨会保留给研究生和博士后，以便向他们介绍 GRC 的主要主题。抑制主要由神经递质 GABA 介导，调节中枢神经系统的各个方面（中枢神经系统）功能并代表治疗的主要目标。科学界致力于抑制神经传递广泛且非常动态。该 GRC 提供了一个汇聚各领域领导人的重要论坛该领域以及早期职业研究人员中冉冉升起的新星。这次会议的目标是增加我们对分子、突触和网络机制的理解有助于发挥关键作用正常和异常中枢神经系统功能中的抑制性神经传递。为实现这一目标，会议将追求特定目标，包括传播有关大脑功能抑制的最新发现和功能障碍，促进领域内的多样性和协作，以及培训的进步研究生和博士后研究员。这些目标将通过召集 34 位世界级演讲者来实现以及来自 3 个国家 11 个不同国家的 9 位讨论领导者在不同的抑制领域积极开展工作各大洲（25 名来自美国；20 名女性），确保国际性和多样性。 GRC 将容纳 200 名与会者在孤立的环境中参加了为期五天的会议。该应用程序的健康相关性是 CNS GRC/GRS 抑制会议上的讨论将确定需要解决的问题与认知、发育以及各种神经和疾病相关领域的实验分辨率涉及抑制失调的精神疾病，包括自闭症、癫痫、精神分裂症、焦虑症、抑郁症和其他疾病。总的来说，预计科学讨论、研究会谈、海报会议以及本次会议不同参与者之间的各种非正式互动将促进我们对中枢神经系统功能和人类疾病的基本机制的理解。